Introduction
• Insights are a synthesis of data and information, potentially from multiple sources, that contribute to an understanding of the true nature of a situation and support informed decisions and actions • Patient insights are generated from patients (directly or indirectly) that provide deep understanding of patient perceptions, experiences and behaviors around their diseases and treatment
• They can help identify and explain why patients are doing what they are doing, and facilitate prediction of their unmet needs and behaviors • Patient insights can provide answers to specific questions and / or test hypotheses, which can in turn translate into targeted drug solutions that better align with the voice of the patient • They can help ensure that drug development programs are aligned with unmet needs and can help overcome access challenges pre and post-launch
Objectives
• To describe the types of patient insights that are most important to generate at different stages of the development timelines and the role they can play in achieving patient access
• To evaluate the different data sources and approaches that can be used to capture patient input and generate insights across the product lifecycle
Methods
• High level definitions into how patient insights can shape patient access across the lifecycle were developed • The types of patient insights were mapped onto a framework modelled around the product lifecycle
• Traditional and non-traditional data sources and approaches for collecting patient insights were evaluated according to feasibility assessment variables and strength of evidence • The most relevant data sources and approaches for the different types of patient insights were defined according to these characteristics 
Results
• The types of patient insights were observed to support access in a number of ways (see Figure 1 ) (illustrated with a number of case studies (data not shown)) • The types of patient insights that were most important to generate were found to vary across the product lifecycle (see Figure 
Conclusions
• This framework has important implications for aligning evidence requirements with unmet patient needs across the product lifecycle • Key findings from this study demonstrate that combining traditional and non-traditional approaches in collecting patient feedback can enhance the understanding of unmet needs, increase patient relevance of programs and boost research efficiency • This can also support the development of the right evidence of product value to optimise patient access
• Non-traditional approaches, passive observation and /or retrospective analysis, demonstrated the ability to complement traditional approaches by providing additional granularity to the understanding of unmet needs • Due to the more informal nature of non-traditional approaches, the ability to analyse data and generate robust insights was significantly more challenging. However, the overall timelines associated with generating patient insights from non-traditional approaches were found to be significantly shorter • The case study analysis, showed the importance of nontraditional approaches in guiding traditional approaches through hypothesis generation 
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